Aclaris therapeutics, inc. reports earnings results for the third quarter ended september 30, 2019

Aclaris therapeutics, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 983,000 compared to usd 1.118 million a year ago. operating loss was usd 22.864 million compared to usd 21.342 million a year ago. net loss was usd 55.319 million compared to usd 32.740 million a year ago. basic loss per share from continuing operations was usd 1.34 compared to usd 1.06 a year ago. for the nine months, total revenue was usd 3.132 million compared to usd 4.379 million a year ago. operating loss was usd 93.505 million compared to usd 60.736 million a year ago. net loss was usd 142.760 million compared to usd 94.187 million a year ago. basic loss per share from continuing operations was usd 3.46 compared to usd 3.04 a year ago.
ACRS Ratings Summary
ACRS Quant Ranking